product_lym

How to order if you are a Patient: Thank you for your interest in our testing. Since all our testing must be ordered by a licensed health care practitioner, please have your current healthcare provider contact us so we can set them up with a Vibrant account.

How to order if you are a Provider: If you are a current Vibrant client, please contact support@vibrant-wellness.com or call your local Territory Sales Manager.

If you don’t have an account with Vibrant Wellness, please fill out a Client Application form to get started.

Tickborne Diseases

A test for detection of tickborne disease and other tickborne diseases

  • Tickborne diseases have more than doubled in 13 years and are 77% of all vector-borne disease reports
    • The most common tickborne diseases (TBDs) in the United States are Anaplasmosis, Babesiosis, Bartonella infections, Ehrlichiosis, Rickettsiosis, Rocky Mountain spotted fever (RMSF), and Lyme disease
  • Lyme Disease accounts for the majority (82%) of all tickborne disease cases

Ticks usually need between 24 and 72 hours to effectively transmit any diseases they are carrying and, if found in time on the host, can be removed before they transmit infectious microorganisms to the host.

Because many symptoms of tickborne diseases are generic or mimic other conditions, these diseases often go undiagnosed for months, increasing the suffering and disease progression of the patient.

Not Available in New York state
Only healthcare providers licensed in their state may order laboratory testing.

Vibrant is committed to providing resources to advanced medical providers in the field of infectious micro-organisms. A thorough and greatly expanded test menu is now available for tickborne diseases, and opportunistic infections commonly found in humans.

All Vibrant Tickborne testing is performed on our proprietary microarray platform:

  • Chemiluminescence-based assay on the Vibrant platform enables the detection of lower level of antibodies in comparison to ELISAEnhanced IgM for early detection
  • Nested amplifications enable up to 16000 fold increase in amplification in comparisonto traditional methods
  • Fully automated technology eliminates inter-sample variability
  • High reproducibility due to high automation

All four panels below can be ordered individually or bundled in combinations based on provider preference.

 

Lyme Plus TBRF (IgG & IgM)

  • Borrelia burgdorferi VlsE1
  • Borrelia burgdorferi C6 peptide
  • Borrelia burgdorferi p18 (DbpB)
  • Borrelia burgdorferi p23-25 (OspC)
  • Borrelia burgdorferi p28
  • Borrelia burgdorferi p30
  • Borrelia burgdorferi p31 (OspA)
  • Borrelia burgdorferi p34 (OspB)
  • Borrelia burgdorferi p39 (BmpA)
  • Borrelia burgdorferi p41
  • Borrelia burgdorferi p45
  • Borrelia burgdorferi p58
  • Borrelia burgdorferi p66
  • Borrelia burgdorferi p83-93
  • Borrelia burgdoferi B31 WCS
  • Borrelia burgdoferi 297 WCS
  • Borrelia mayonii
  • Borrelia afzelii BmpA
  • Borrelia afzelii DbpA
  • Borrelia afzelii OspA
  • Borrelia afzelii OspC
  • Borrelia afzelii p100
  • Borrelia garinii DbpA
  • Borrelia garinii OspC
  • Borrelia bavariensis DbpA
  • Borrelia bavariensis p58
  • Borrelia bavariensis VlsE1
  • Borrelia spielmanii DbpA
  • Borrelia spielmanii OspC
  • Borrelia hermsii
  • Borrelia turicatae
  • Borrelia miyamotoi
  • Borrelia andersonii
  • Borrelia maritima
  • Borrelia californiensis
  • Borrelia bissettiae
  • Borrelia lusitaniae
  • Borrelia valaisiana
  • Borrelia yangtzensis
  • Borrelia turcica

Lyme plus TBRF (PCR)

  • Borrelia burgdorferi
  • Borrelia mayonii
  • Borrelia afzelii
  • Borrelia garinii
  • Borrelia bavariensis
  • Borrelia spielmanii
  • Borrelia hermsii
  • Borrelia turicatae
  • Borrelia lonestari

Coinfections 1 (IgG & IgM)

  • Babesia microti IRA
  • Babesia microti p32
  • Babesia microti p41
  • Babesia microti WCS
  • Babesia duncani
  • Bartonella henselae 17 kDa
  • Bartonella henselae 26 kDa
  • Bartonella henselae SucB
  • Bartonella elizabethae
  • Bartonella vinsonii
  • Bartonella quintana
  • Anaplasma phagocytophilum Msp5
  • Anaplasma phagocytophilum Msp2 (p44)
  • Anaplasma phagocytophilum OmpA
  • Ehrlichia chaffeensis

Coinfections 1 (PCR)

  • Babesia microti
  • Babesia duncani
  • Bartonella henselae
  • Bartonella elizabethae
  • Bartonella vinsonii
  • Bartonella quintana
  • HGA Anaplasma phagocytophilum
  • HME Ehrlichia chaffeensis

Coinfections 2 (IgG & IgM)

  • Rickettsia typhi OmpB
  • Rickettsia typhi Surface antigen
  • Powassan Virus
  • Tickborne Encephalitis Virus
  • West Nile Virus
  • Chlamydophila pneumoniae
  • Coxsackie Virus
  • Mycoplasma pneumoniae

Coinfections 2 (PCR)

  • Rickettsia rickettsii
  • Rickettsia typhi
  • Powassan virus
  • Tickborne Encephalitis Virus
  • West Nile Virus
  • Chlamydophila pneumoniae
  • Coxsackie virus
  • Mycoplasma pneumoniae

Opportunistic Infections (IgG & IgM)

  • Cytomegalovirus EIA Antigen
  • Cytomegalovirus GlyB
  • Cytomegalovirus p150
  • Cytomegalovirus p28
  • Cytomegalovirus p52
  • Cytomegalovirus p65
  • Cytomegalovirus p38
  • Epstein Barr Virus EA Antigen
  • Epstein Barr Virus EBNA1
  • Epstein Barr Virus VCA gp125
  • Epstein Barr Virus p18
  • Epstein Barr Virus p23
  • Parvovirus B19 VLP VP2
  • Parvovirus B19 VLP VP1/Vp2 Co Capsid
  • Toxoplasma gondii Crude Extract
  • Toxoplasma gondii MIC3
  • Toxoplasma gondii p24
  • Toxoplasma gondii p29
  • Toxoplasma gondii p30
  • HSV-1
  • HSV-2
  • HHV-6
  • HHV-7
  • Streptococcal A

Opportunistic Infections (PCR)

  • Parvovirus B19
  • Toxoplasma gondii

Tickborne diseases can be acquired throughout the United States from a variety of ticks, which carry and pass on different microorganisms to humans and animals. Symptoms may be generic and have overlap with other conditions, and therefore, be difficult to associate with a tickborne disease.

Symptoms Associated with Tickborne Diseases Include:

  • Fever and/or chills
  • headache
  • Bell’s palsy
  • neck stiffness
  • fatigue
  • muscle or joint aches/pains
  • GI symptoms : nausea, vomiting, diarrhea
  • rash
  • loss of appetite
  • weight loss
  • change in cognitive or psychological status
  • anemia
  • enlarged, tender lymph nodes
  • painful abdomen
  • dizziness or shortness of breath
  • numbness or weakness in limbs

Tickborne disease symptoms and disease progression can also often be more severe in the elderly and immunocompromised.

The Vibrant Immunochip is made from recombinant proteins of several species of Borrelia burgdorferi, and not just from B31 used by other western blot tests. Vibrant criteria for detection has higher sensitivity and specificity than the two-tier testing by CDC criteria, as demonstrated by internal studies. This eliminates doubt for clinicians.

The Vibrant Tickborne Diseases panel is the first of its kind to be run on a silicon micro-array platform, providing the highest level of specificity and sensitivity in the industry for detecting tickborne diseases.

Patients often present with a range of non-specific symptoms that may be Lyme, or other conditions that have symptom overlap. Patients with diagnosed Lyme may also experience resurgence of symptoms, which might suggest co-infections. Co-infections are complex and should be included in an initial screen of Lyme and related illnesses.

Vibrant has the most comprehensive antibody (indirect) and DNA (direct) test for detection of Lyme and co-infections that, in most cases, can assist the clinician in assessing these situations and lead to the correct diagnosis.

Because standard treatment for tickborne diseases usually involves courses of antibiotics that are prolonged, this can also leave the patient at risk for multiple chronic inflammatory symptoms or conditions due to impact to the microbiome. It is recommended that patients being treated for tickborne diseases undergo regular microbiome screening during antibiotic therapy, such as the Vibrant Gut Zoomer or Vibrant Gut Pathogens tests.

Do I need to be fasting for the Tickborne Diseases test?

As with all antibody testing, fasting is not required.

Recommended Tests to Consider

menu_neural
Neural Zoomer
menu_wheat
Wheat Zoomer
menu_gut
Gut Zoomer

Regulatory Statement

Vibrant testing does not demonstrate absolute positive and negative predictive values for any disease state or condition. Its clinical utility has not been fully established. Vibrant validates the accuracy and precision of the testing but not of its clinical or diagnostic value. So these tests are for wellness and informational purpose only. Vibrant is actively doing clinical research on these samples, de-identified from patients under an IRB and will make research publications towards the same as and when the clinical utility is well established. These tests have been laboratory developed and their performance characteristics determined by Vibrant America LLC, a CLIA-certified laboratory performing the test CLIA#:05D2078809. The test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. The general wellness test intended uses relate to sustaining or offering general improvement to functions associated with a general state of health while making reference to diseases or conditions. Content provided for informational purposes only and should not be construed as medical advice. Content provided to help you make a healthy lifestyle, dietary, and treatment choices in consultation with your healthcare provider. It is intended to be used as a tool to encourage a general state of health and well-being. Please consult with your healthcare practitioner for diagnosis and treatment considerations. The Vibrant Wellness platform provides tools for you to track and analyze your general wellness profile.